ALSP Orchid Acquisition Corp I’s $172.5 Million IPO

Conyers, working alongside Cooley LLP, assisted ALSP Orchid on the IPO.

ALSP Orchid Acquisition Corp I  a special purpose acquisition company, on its US$172.5 million initial public offering on the Nasdaq Global Market. 

The IPO is comprised of an offering of 17,250,000 units at a price of $10.00 per unit which includes the underwriters’ overallotment. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share.

The units are listed on Nasdaq and began trading under the ticker symbol “ALORU” on November 19, 2021.

After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ALOR” and “ALORW,” respectively.

Stifel, Nicolaus & Company, Incorporated and Nomura Securities International, Inc. acted as joint book-running managers of the offering.

ALSP Orchid is a newly organized blank check company formed in the Cayman Islands by venture capital firm Accelerator Life Science Partners, a firm focused on building next-generation life science companies that solve important healthcare needs with cutting-edge breakthroughs in medicine and science.

The Conyers’ team included Partner Matthew Stocker (Picture), Counsel Alex Davies and Associate Matthew Harkness. 

Involved fees earner: Alex Davies – Conyers Dill & Pearman; Matthew Harkness – Conyers Dill & Pearman; Matthew Stocker – Conyers Dill & Pearman;

Law Firms: Conyers Dill & Pearman;

Clients: ALSP Orchid Acquisition Corporation I (;

Author: Sonia Carcano